APYX — APYX MEDICAL CORPORATION
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying APYX?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 3 tracked investors who changed their APYX position last quarter, 0 bought and 3 sold (0% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).
- +1 tracked investors reported holding APYX at their latest filing
- −3 tracked investors reduced or exited last quarter (1 reduced, 2 sold out)
- −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About APYX MEDICAL CORPORATION (APYX)
APYX MEDICAL CORPORATION (APYX) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $1M. Across recent filings, tracked investors recorded 4 new positions, 4 increased, 4 reduced, and 3 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in APYX
How many top investors track APYX
Only 1 tracked investor report this position.
APYX Ownership Composition
How APYX MEDICAL CORPORATION is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting APYX
2 tracked investors have since exited this position — listed separately below.
- Izzy EnglanderSep 30, 2026Millennium ManagementShares191.8KValue$469.8K% Portfolio0.00%
Previously held APYX
These investors reported APYX in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Ken Griffin | Citadel Advisors | 168.3K | $755.9K | Jun 30, 2026 |
| Steve Cohen | Point72 Asset Management | 26.4K | $118.3K | Jun 30, 2026 |
Recent activity
- Reduced$469.8K(-20.98%)Nov 16, 2026
- Sold$0(-100.00%)Nov 16, 2026
- Sold$0(-100.00%)Nov 16, 2026
- $324.4KFeb 17, 2026
- Increased$967K(182.72%)May 15, 2026
- Reduced$1.1M(-7.40%)Aug 14, 2026
- Increased$39.6K(17.22%)Nov 14, 2024
- Reduced$51.6K(-43.24%)May 15, 2025
- Sold$0(-100.00%)Aug 14, 2025
- Increased$755.9K(56.17%)Aug 14, 2026
- New$77.7KFeb 17, 2026
- Increased$128.3K(56.75%)May 15, 2026
- Reduced$118.3K(-24.23%)Aug 14, 2026
- New$36.6KAug 14, 2024
- $101.5KMay 15, 2024
Frequently asked questions
- How many institutional investors hold APYX?
- 1 tracked institutional investor disclosed a position in APYX (APYX MEDICAL CORPORATION) in their most recent 13F filing.
- Who is the largest institutional holder of APYX?
- Izzy Englander, Millennium Management, holds the largest disclosed position in APYX, valued at $1M.
- Did institutional ownership of APYX increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 4 increased, 4 reduced, and 3 fully exited APYX.
- Where does this APYX ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.